514 related articles for article (PubMed ID: 30845990)
1. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
[No Abstract] [Full Text] [Related]
3. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
[TBL] [Abstract][Full Text] [Related]
4. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
[No Abstract] [Full Text] [Related]
5. Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction.
Jiang Y; Sun SJ; Zhen Z; Wei R; Zhang N; Liao SY; Tse HF
Stem Cell Res Ther; 2021 Jan; 12(1):13. PubMed ID: 33413626
[TBL] [Abstract][Full Text] [Related]
6. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
[TBL] [Abstract][Full Text] [Related]
7. Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes.
Jiang X; Yang Z; Dong M
Stem Cell Res Ther; 2020 Jul; 11(1):297. PubMed ID: 32680540
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human embryonic stem cell-derived MSCs.
Chen W; Liu X; Chen Q; Bao C; Zhao L; Zhu Z; Xu HHK
J Tissue Eng Regen Med; 2018 Jan; 12(1):191-203. PubMed ID: 28098961
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
[TBL] [Abstract][Full Text] [Related]
10. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
[TBL] [Abstract][Full Text] [Related]
11. Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin.
Tanaka Y; Kadota S; Zhao J; Kobayashi H; Okano S; Izumi M; Honda Y; Ichimura H; Shiba N; Uemura T; Wada Y; Chuma S; Nakada T; Tohyama S; Fukuda K; Yamada M; Seto T; Kuwahara K; Shiba Y
Stem Cell Res Ther; 2023 Sep; 14(1):240. PubMed ID: 37679796
[TBL] [Abstract][Full Text] [Related]
12. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
[TBL] [Abstract][Full Text] [Related]
13. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
Fan C; Fast VG; Tang Y; Zhao M; Turner JF; Krishnamurthy P; Rogers JM; Valarmathi MT; Yang J; Zhu W; Zhang J
J Mol Cell Cardiol; 2019 Dec; 137():25-33. PubMed ID: 31629738
[TBL] [Abstract][Full Text] [Related]
15. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.
Tabei R; Kawaguchi S; Kanazawa H; Tohyama S; Hirano A; Handa N; Hishikawa S; Teratani T; Kunita S; Fukuda J; Mugishima Y; Suzuki T; Nakajima K; Seki T; Kishino Y; Okada M; Yamazaki M; Okamoto K; Shimizu H; Kobayashi E; Tabata Y; Fujita J; Fukuda K
J Heart Lung Transplant; 2019 Feb; 38(2):203-214. PubMed ID: 30691596
[TBL] [Abstract][Full Text] [Related]
16. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells.
Wei H; Tan G; Manasi ; Qiu S; Kong G; Yong P; Koh C; Ooi TH; Lim SY; Wong P; Gan SU; Shim W
Stem Cell Res; 2012 Sep; 9(2):87-100. PubMed ID: 22683798
[TBL] [Abstract][Full Text] [Related]
17. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
[TBL] [Abstract][Full Text] [Related]
18. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
19. Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.
Mattapally S; Zhu W; Fast VG; Gao L; Worley C; Kannappan R; Borovjagin AV; Zhang J
Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H327-H339. PubMed ID: 29631371
[TBL] [Abstract][Full Text] [Related]
20. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
